The Centers for Medicare and Medicaid Services has created a system in which Wall Street actors and insurance conglomerates have extracted large profits at the expense of Medicare, its patients and taxpayers – according to a new report co-authored by a Cornell professor.
A preclinical study has shown that colorectal pre-cancerous lesions known as serrated polyps, and the aggressive tumors that develop from them, depend on the ramped-up production of cholesterol, which points to the possibility of using cholesterol-lowering drugs to prevent or treat such tumors.
A new gene-editing tool created by Weill Cornell Medicine investigators will enable cancer researchers to study the impact of specific genetic changes in preclinical models.
An interdisciplinary collaboration used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice, an approach that could lead to therapeutic treatments for infertility.
The $1.7 million grant will help scientists with expertise in artificial intelligence and machine learning to address complex biomedical challenges in nutrition and health.
The financial stability of providers and their ability to serve patients is being threatened by Wall Street, according to new research co-authored by ILR Professor Rose Batt.
Using low-frequency radio waves to send blood pressure data, a group of students has provided a proof of concept that could enable in-home health care for people without cellular or broadband access.
Only one in five Medicaid enrollees diagnosed with hepatitis C virus started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.
Deer hunters were more likely to be swayed by social media messages about the potential risks of chronic wasting disease if they came from a source they believed aligned with their own views and values.
Removing race information from cardiovascular risk calculators – which predict the probability of developing heart disease – doesn’t affect patients’ risk scores, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.